Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York

University of Pittsburgh Cancer Institute (UPCI), Pittsburgh

NCI - Center for Cancer Research, Bethesda

Wake Forest University at Clemmons, Clemmons

Wake Forest University Health Sciences, Winston-Salem

Wake Forest Baptist Health - Wilkes Medical Center, Wilkesboro

Wake Forest Baptist Health - Hematology Oncology - Statesville, Statesville

University of Kentucky/Markey Cancer Center, Lexington

Wayne State University/Karmanos Cancer Institute, Detroit

Weisberg Cancer Treatment Center, Farmington Hills

University of Kansas Cancer Center - Lee's Summit, Lee's Summit

University Health Truman Medical Center, Kansas City

University of Kansas Cancer Center at North Kansas City Hospital, North Kansas City

University of Kansas Cancer Center - North, Kansas City

Lawrence Memorial Hospital, Lawrence

The University of Kansas Cancer Center - Olathe, Olathe

University of Kansas Cancer Center, Kansas City

University of Kansas Clinical Research Center, Fairway

University of Kansas Hospital-Westwood Cancer Center, Westwood

University of Kansas Cancer Center-Overland Park, Overland Park

University of Kansas Hospital-Indian Creek Campus, Overland Park

University of Kansas Health System Saint Francis Campus, Topeka

Mercy Hospital Pittsburg, Pittsburg

Salina Regional Health Center, Salina

HaysMed, Hays

Parkland Memorial Hospital, Dallas

UT Southwestern/Simmons Cancer Center-Dallas, Dallas

UCHealth University of Colorado Hospital, Aurora

Los Angeles General Medical Center, Los Angeles

USC / Norris Comprehensive Cancer Center, Los Angeles

USC Norris Oncology/Hematology-Newport Beach, Newport Beach

University of California Davis Comprehensive Cancer Center, Sacramento

Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon